Vitamin D: A new anti-infective agent?

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 76-83

  Borella, Elisabetta ^a,b   Nesher, Gideon ^b,c   Israeli, Eitan ^b   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Antibiotic; Autoimmunity; HIV; Infection; Tuberculosis; Vitamin D

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CALCITRIOL; CATHELICIDIN; COLECALCIFEROL; PLACEBO; VITAMIN D;

ARTICLE; DENGUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION; OTITIS MEDIA; PHAGOCYTE; PNEUMONIA; RESPIRATORY TRACT INFECTION; SEPSIS; SUN EXPOSURE; TUBERCULOSIS; VIRUS HEPATITIS; VITAMIN D DEFICIENCY;

ANTIBIOTIC; AUTOIMMUNITY; HIV; INFECTION; TUBERCULOSIS; VITAMIN D;

ANIMALS; ANTI-INFECTIVE AGENTS; DENGUE; HEPATITIS; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; SEPSIS; TUBERCULOSIS; VITAMIN D;

EID: 84901490912     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12321     Document Type: Article

References (76)

1. Pludowski, P., M.F. Holick, S. Pilz, et al. 2013. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 12: 976-989.
2. Ma, J., Z. Ma, W. Li, et al. 2013. The mechanism of calcitriol in cancer prevention and treatment. Curr. Med. Chem. 20: 4121-4130.
3. Agmon-Levin, N., E. Theodor, R.M. Segal & Y. Shoenfeld 2013. Vitamin D in systemic and organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 45: 256-266
4. Shuler, F.D., J. Hendrix, S. Hodroge & A. Short 2013. Antibiotic-like actions of vitamin D. W. V. Med. J. 109: 22-25.
5. Dheda, K. & G.B. Migliori 2012. The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? Lancet. 379: 773-775.
6. Grad, R. 2004. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm. Hist. 46: 106-120.
7. Mawer, E.B., G. Jones, M. Davies, et al. 1998. Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1, 24-dihydroxyvitamin D2 detectable in human serum. J. Clin. Endocrinol. Metab. 83: 2156-2166.
8. Trang, H.M., D.E. Cole, L.A. Rubin, et al. 1998. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr. 68: 854-858.
9. Mattila, P. 1995. Analysis of cholecalciferol, ergocalciferol and their 25-hydroxylated metabolites in foods by HPLC. PhD thesis. Helsinki University. Helsinki.
10. Ovesen, L., R. Andersen & J. Jakobsen 2003. Geographical differences in vitamin D status, with particular reference to European countries. Proc. Nutr. Soc. 62: 813-821.
11. Ovesen, L., C. Brot & J. Jakobsen 2003. Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Ann. Nutr. Metab. 47: 107-113.
12. Lips, P. 2010. Worldwide status of vitamin D nutrition. J. Steroid Biochem. Mol. Biol. 121: 297-300.
13. Mithal, A., D.A. Wahl, J.P. Bonjour, et al. 2009. Global vitamin D status and determinants of Hypovitaminosis D. Osteoporos. Int. 20: 1807-1820.
14. Wang, T.T., F.P. Nestel, V. Bourdeau, et al. 2004. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173: 2909-2912.
15. Gombart, A.F., N. Borregaard & H.P. Koeffler 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3. FASEB J. 19: 1067-1077.
16. Liu, P.T., S. Stenger, H. Li, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 311: 1770-1773.
17. Yuk, J.M., D.M. Shin, H.M. Lee, et al. 2009. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microb. 6: 231-243.
18. Wang, T.T., B. Dabbas, D. Laperriere, et al. 2010. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta-2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 285: 2227-2231.
19. Levine, B., N. Mizushima & H.W. Virgin 2011. Autophagy in immunity and inflammation. Nature 469: 323-335.
20. Deretic, V. 2011. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol. Rev. 240: 92-104.
21. Koeffler, H.P., H. Reichel, J.E. Bishop & A.W. Norman 1985. Gamma-interferon stimulates production of 1, 25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun. 127: 596-603.
22. Rockett, K.A., R. Brookes, I. Udalova, et al. 1998. 1, 25-dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 66: 5314-5321.
23. Verway, M., M. Bouttier, T.T. Wang, et al. 2013. Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. Tuberculosis infection. PLoS Pathog. 9: e1003407.
24. van Etten, E. & C. Mathieu 2005. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J. Steroid Biochem. Mol. Biol. 97: 93-101.
25. + CD4 regulatory t cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytual virus infection. J. Immunol. 185: 2382-2392.
26. + regulatory T cells protect the liver from immune damage and compromise virus control during experimental hepatitis B virus infection in mice. Hepatology 56: 873-878.
27. Veiga-Parga, T., S. Sehrawat & B.T. Rouse 2013. Role of regulatory T cells during virus infection. Immunol. Rev. 255: 182-196.
28. Murray, S. 2006. Challenges of tuberculosis control. CMAJ. 174: 33-34.
29. Zignol, M., W. van Gemert, D. Falzon, et al. 2012. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull. World Health Organ. 90: 111D-119D.
30. Malik, Z.A., G.M. Denning & D.J. Kusner 2007. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 191: 287-302.
31. Campbell, G.R. & S.A. Spector 2012. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 8: e1002689.
32. Nursyam, E.W., Z. Amin & C.M. Rumende 2006. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indonesia 38: 3-5.
33. Rathored, J., S.K. Sharma, B. Singh, et al. 2012. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D. Int. J. Tuberc. Lung Dis. 16: 1522-1528.
34. Elkington, P.T., J.E. Emerson, L.D. Lopez-Pascua, et al. 2005. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J. Immunol. 175: 5333-5340.
35. Coussens, A., P.M. Timms, B.J. Boucher, et al. 2009. 1-alpha, 25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 127: 539-548.
36. Holick, M.F. & T.C. Chen 2008. Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87: S1080-S1086.
37. Berry, D.J., K. Hesketh, C. Power & E. Hypponen 2011. Vitamin D status has a linear association with seasonal infections and lung function in british adults. Br. J. Nutr. 106: 1433-1440.
38. Bergman, P., A.U. Lindh, L. Bjorkhem-Bergman & J.D. Lindh 2013. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 8: e65835.
39. Mao, S. & S. Huang 2013. Vitamin D supplementation and risk of respiratory tract infections: a meta-analysis of randomized controlled trials. Scand. J. Infect. Dis. 45: 696-702.
40. Cayir, A., M.I. Turan, O. Ozkan, et al. 2013. Serum vitamin D levels in children with recurrent otitis media. Eur. Arch. Otorhinolaryngol. DOI:10.1007/s00405-013-2455-7.
41. Thornton, K.A., C. Marin, M. Mora-Plazas & E. Villamor 2013. Vitamin D deficiency associated with increased incidence of gastrointestinal and ear infections in school-age children. Pediatr. Infect. Dis. J. 32: 585-593.
42. Youssef, D., W.B. Grant & A.N. Peiris 2012. Vitamin D deficiency: a potential risk factor for Clostridium difficile infection. Risk Manage. Health Care Pol. 5: 115-116.
43. Chromek, M., Z. Slamova, P. Bergman, et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12: 636-641.
44. Hertting, O., A. Holm, P. Luthje, et al. 2010. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One 5: e15580.
45. Aslan, S., I. Akil, G. Aslan, et al. 2012. Vitamin D receptor gene polymorphism in children with urinary tract infection. Pediatr. Nephrol. 27: 417-421.
46. Harris, A.L. 2011. Vitamin D deficiency and bacterial vaginosis in pregnancy: examining the link. Nurs. Womens Health. 15: 423-430.
47. Bodnar, L.M., M.A. Krohn & H.N. Simhan 2009. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr. 139: 1157-1161.
48. Dunlop, A.L., R.N. Taylor, V. Tangpricha, et al. 2011. Maternal vitamin D, folate, and polyunsaturated fatty acid status and bacterial vaginosis during pregnancy. Infect. Dis. Obstet. Gynecol. 2011: 216217.
49. Hensel, K.J., T.M. Randis, S.E. Gelber & A.J. Ratner 2011. Pregnancy-specific association of vitamin D deficiency and bacterial vaginosis. Am. J. Obstet. Gynecol. 204: 41.e1-41.e9.
50. Farnik, H., J. Bojunga, A. Berger, et al. 2013. Low vitamin D serum concentration is associated with high levels of hepatitis B virus (HBV) replication in chronically infected patients. Hepatology 58: 1270-1276.
51. Lange, C.M., J. Bojunga, E. Ramos-Lopez, et al. 2011. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J. Hepatol. 54: 887-893.
52. Mandorfer, M., T. Reiberger, B.A. Payer, et al. 2012. Low vitamin D levels are associated with impaired virologic response to PEGIFN+RBV therapy in HIV/HCV coinfected patients. AIDS. 27: 227-232.
53. Terrier, B., F. Jehan, M. Munteanu, et al. 2012. Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology 51: 2083-2090.
54. Ansemant, T., S. Mahy, C. Piroth, et al. 2013. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect. Dis. 13: 7.
55. Aziz, M., B. Livak, J. Burke-Miller, et al. 2013. Vitamin D insufficiency may impair CD4 recovery among women's interagency HIV study participants with advanced disease on HAART. AIDS. 27: 573-578.
56. Mehta, S., E. Giovannucci, F.M. Mugusi, et al. 2010. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 5: e8770.
57. Haug, C., F. Muller, P. Aukrust & S.S. Froland 1994. Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J. Infect. Dis. 169: 889-893.
58. Mehta, S., D.J. Hunter, F.M. Mugusi, et al. 2009. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J. Infect. Dis. 200: 1022-1030.
59. Campbell, G.R. & S.A. Spector 2012. Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy. 8: 1523-1525.
60. Sudfeld, C.R., E.L. Giovannucci, S. Isanaka, et al. 2013. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J. Infect. Dis. 207: 378-385.
61. Loke, H., D. Bethell, C.X. Phuong, et al. 2002. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc gamma receptor IIa genes. Am. J. Trop. Med. Hyg. 67: 102-106.
62. Puerta-Guardo, H., F. Medina, S.I. De la Cruz Hernandez, et al. 2012. The 1alpha, 25-dihydroxyvitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (huh-7) cell lines and cytokine production in the infected monocytes. Antiviral Res. 94: 57-61.
63. Sanchez-Valdez, E., M. Delgado-Aradillas, J.A. Torres-Martinez & J.M. Torres-Benitez 2009. Clinical response in patients with dengue fever to oral calcium plus vitamin D administration: study of 5 cases. Proc. West Pharmacol. Soc. 52: 14-17.
64. Horiuchi, H., I. Nagata & K. Komoriya 1991. Protective effect of vitamin D3 analogues on endotoxin shock in mice. Agents Actions 33: 343-348.
65. Moller, S., F. Laigaard, K. Olgaard & C. Hemmingsen 2007. Effect of 1, 25-dihydroxy-vitamin D3 in experimental sepsis. Int. J. Med. Sci. 4: 190-195.
66. Braun, A., D. Chang, K. Mahadevappa, et al. 2011. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit. Care Med. 39: 671-677.
67. Nguyen, H.B., B. Eshete, K.H. Lau, et al. 2013. Serum 1, 25-dihydroxyvitamin D: an outcome prognosticator in human sepsis. PLoS One 8: e64348.
68. Bergman, P., A.C. Norlin, S. Hansen, et al. 2012. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2. DOI:10.1136/bmjopen-2012-001663.
69. Camargo, C.A. Jr., D. Ganmaa, A.L. Frazier, et al. 2012. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in mongolia. Pediatrics 130: e561-e567.
70. Jorde, R., M. Witham, W. Janssens, et al. 2012. Vitamin D supplementation did not prevent influenza-like illness as diagnosed retrospectively by questionnaires in subjects participating in randomized clinical trials. Scand. J. Infect. Dis. 44: 126-132.
71. Laaksi, I., J.P. Ruohola, V. Mattila, et al. 2010. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J. Infect. Dis. 202: 809-814.
72. Urashima, M., T. Segawa, M. Okazaki, et al. 2010. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91: 1255-1260.
73. Li-Ng, M., J.F. Aloia, S. Pollack, et al. 2009. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect. 137: 1396-1404.
74. Manaseki-Holland, S., Z. Maroof, J. Bruce, et al. 2012. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 379: 1419-1427.
75. Manaseki-Holland, S., G. Qader, M. Isaq Masher, et al. 2010. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop. Med. Int. Health. 15: 1148-1155.
76. Murdoch, D.R., S. Slow, S.T. Chambers, et al. 2012. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA. 308: 1333-1339.